Medication info

F.D. Caine 1:100,000 Injection

Prescription medicationInjection
Ingredient · strength
Lidocaine Hydrochloride›20mg / 1mLEpinephrine›0.01mg / 1mL
Manufacturer / importer
HonexKorea
Appearance
Colorless, transparent liquid in a cartridge-type ampoule
Packaging
50 ampoules/box [1.8 mL/ampoule x 50]
Approval status
Active

MFDS item code 200308159 · Notified 2003.12.12 · Insurance code 685200031,685200033

Summary

Main use
Pain prevention through dental conduction or infiltration anesthesia
Who receives it
Adults
Adult administration
Conduction or infiltration anesthesia: Use 0.3 ~ 2 mL of this medicine (equivalent to 6 ∼ 40 mg of lidocaine hydrochloride).

Ingredients

Importer
HonexKorea

Efficacy & effects

Pain prevention through dental conduction or infiltration anesthesia

View approved original text

The methods of local anesthesia used to reduce pain during dental treatment are conduction anesthesia and infiltration anesthesia. Conduction anesthesia involves injecting the drug into the major branches of the nerve to block sensation over a wide area, while infiltration anesthesia directly injects the drug into the tissues surrounding the treatment area to block local sensation. These two anesthesia methods effectively block pain, allowing the patient to receive treatment comfortably. Use of these anesthesia methods during dental procedures proceeds without discomfort.

How it is given

Adult administration

Conduction or infiltration anesthesia: Use 0.3 ~ 2 mL of this medicine (equivalent to 6 ∼ 40 mg of lidocaine hydrochloride).

Precautions

This medication is an amide-type local anesthetic and should not be used in certain patients. Particularly, patients who have had allergic reactions to this medication or other amide-type local anesthetics, those allergic to vasoconstrictors, and patients with conditions such as hypertension, atherosclerosis, heart failure, hyperthyroidism, diabetes, and vascular spasms should not be administered this drug. Additionally, careful administration is needed in patients using halogen-containing inhalational anesthetics such as halothane or those taking tricyclic antidepressants or MAO inhibitors. This medication contains sodium metabisulfite, which may cause allergic reactions or asthma attacks in susceptible individuals, especially in patients with asthma. During administration, adverse reactions such as shock symptoms, hypotension, pulse irregularities, and respiratory depression may occur, so careful monitoring of the patient is necessary. If these abnormal symptoms arise, administration should be immediately discontinued and appropriate treatment should be provided. There is also a rare risk of a severe side effect called malignant hyperthermia, so if symptoms such as sudden temperature rise or muscle rigidity occur, drug administration must be stopped immediately, and specialized treatment is required. Central nervous system disturbances may present as tremors, seizures, drowsiness, anxiety, dizziness, and nausea, which should be closely monitored. Allergic reactions such as skin rash, swelling, and difficulty breathing may also occur, and any abnormal symptoms should be reported to medical personnel immediately. When using this drug, it is important to be prepared to perform first aid promptly in case of shock or toxicity. As much as possible, use the lowest concentration and the minimum effective dose; administer only a small amount slowly in highly vascular areas to prevent rapid absorption. When injecting, care should be taken to avoid the needle entering a blood vessel, and the patient's overall condition should be thoroughly checked. Women who are pregnant or may become pregnant should use this drug only when the benefits outweigh the risks, as its safety has not been established. The components of this drug may be excreted in small amounts in breast milk, but the effects on nursing infants are not clearly known, so use should be discussed with medical personnel beforehand. Elderly patients may be more sensitive to the epinephrine contained in this medication, so their condition should be monitored closely when administered. Particularly in cases of epidural anesthesia, the anesthetic coverage may expand in elderly patients, so the dosage should be adjusted with caution. Lastly, this drug should not be used for ophthalmic purposes.

Side effects

Shock, hypotension, pallor, abnormal pulse, respiratory depression, malignant hyperthermia, tachycardia, arrhythmia, blood pressure fluctuations, rapid increase in body temperature, muscle rigidity, blood reddening, cyanosis, hyperventilation, sweating, acidosis, hyperkalemia, myoglobinuria, tremors, seizures, drowsiness, anxiety, agitation, neglect, dizziness, nausea, vomiting, urticaria, edema, respiratory distress due to bronchoconstriction, anaphylactic reaction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a tightly sealed container that is protected from light. It is important to maintain room temperature between 10 degrees and 30 degrees Celsius. Proper storage will help preserve the efficacy of the drug for a longer period.

Appearance and packaging

Appearance

Colorless, transparent liquid in a cartridge-type ampoule

Package unit

50 ampoules/box [1.8 mL/ampoule x 50]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.